In the past two decades many studies have been devoted to the involvement of
the periportal (zone-1) and perivenous (zone-3) hepatocytes in bile formation and hepatobiliary
transport of endogenous and exogenous compounds. It became clear that such a heterogeneity
in transport function can, in principle, be due to the different localization of the
cells in the acinus with respect to the incoming blood, to intrinsic differences between the
cells or to both. In this review we first discuss the techniques used to study hepatocyte
heterogeneity in hepatobiliary transport function. Combinations of such techniques can be
used to discriminate between cellular heterogeneity due to acinar localization as opposed to
intrinsic differences. These techniques include: normal and retrograde perfusions of isolated
perfused livers; autoradiographic, fluorimetrie and histochemical localization of injected
substrates; separation of isolated hepatocytes into fractions enriched in periportal and perivenous
cells; measurements of fluorescent surface signals with microlight guides; selective
zonal toxicity, and pharmacokinetic modelling and analysis. Subsequently, for each of the
rate-limiting steps in the hepatobiliary transport of organic compounds, the basic mechanisms
are summarized and the available knowledge on the involvement of the cells from the
various zones in these transport steps is discussed. The available literature data indicate that
heterogeneity in transport function is often due to the localization of the cells in the acinus:
the periportal cells are the first to come into contact with the portal blood and are thus
exposed to the highest substrate concentration. Consequently they obtain the most prominent
task in further disposition of the particular compound. It follows that the extent of
involvement of the perivenous cells in drug disposition is implicitly determined by the
activity of the periportal cells. Because of the potential saturation of elimination processes in
the periportal cells, the involvement of perivenous cells may vary with the input concentration. In addition, real intrinsic differences have been established in the hepatobiliary transport
of some substrates. These are probably based on differences in the cellular content of
carrier- and receptor-binding and/or metabolizing proteins. In some cases these intrinsic
differences may be secondary to existing sinusoidal gradients of endogenous compounds,
such as O(2), amino acids, bile acids or monosaccharides. Yet, data on the heterogeneity of
hepatocytes in the various transport steps are far from complete or are even totally lacking,
especially for human liver. A multi-experimental approach and advanced technology will be
needed in the future to gain more insight into the acinar organization of bile formation and
hepatobiliary transport of drugs in the human.